Rising prevalence of urinary tract infections, growing geriatric population, and rapid technological advancements are driving the global urinary tract infection testing market. By test kit, laboratory test kit segment would dominate the market in 2031.
PORTLAND, Oregon., February 4, 2023 /PRNewswire/ — Allied Market Research released a report titled “Urinary Tract Infection Testing Market by type of infection (urethritis, cystitis, pyelonephritis), by type of test (urinalysis, urine cultures, sensitivity tests), by end user (hospitals, diagnostic laboratories, research institutes), by kit (Home Test Kits, Lab Test Kits): Global Opportunities Analysis and Industry Forecast, 2021-2031According to the report, the global urinary tract infection testing industry is estimated to generate $574 million in 2021 and $1 billion by 2031, growing at a CAGR of 6.2% from 2022 to 2031. The report offers a detailed analysis of changing market trends, major segments, major investment pockets, value chain, regional landscape and competitive scenario.
Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/31812
Drivers, constraints and opportunities
Rising prevalence of urinary tract infections, growing geriatric population, and rapid technological advancements are fueling the growth of the global urinary tract infection testing market. However, errors such as false negative or false positive results in UTI tests can hamper the growth of the global market. On the other hand, the availability of self-testing kits for urinary tract infection testing and the increasing prevalence of diabetes globally will present new growth opportunities for the global urinary tract infection testing market in the coming years. coming.
- The COVID-19 pandemic had a moderate impact on the global urinary tract infection testing market during the initial period of the pandemic owing to the low number of hospitalizations.
- Strict lockdowns imposed by governments around the world have had a significant impact on the number of UTI tests performed. Additionally, supply chain constraints, stalled logistics due to shutdowns, and other regulatory restrictions have hampered the growth of the market.
- The market recovered after the pandemic.
Lab Test Kits Segment to Dominate During the Forecast Period
Based on test kits, the laboratory test kits segment contributed the largest three-quarters share of the global urinary tract infection test market in 2021 and is expected to maintain its leadership during the period of forecast. Moreover, the same segment is expected to experience the fastest CAGR of 6.3% from 2022 to 2031. This is because lab test kits can produce accurate test results on a smartphone. Moreover, patients can check whether they are free from infection or not just by using lab UTI test kits.
The cystitis segment will maintain significant revenue growth in 2031
Based on the type of infection, the cystitis segment held the largest share of more than half of the global urinary tract infection testing market in 2021 and is expected to maintain significant growth during the forecast period . Each year, approximately 10 out of 100 women worldwide are diagnosed with cystitis. However, the pyelonephritis segment is expected to have the highest CAGR of 6.5% in 2031, as pyelonephritis is one of the most common kidney diseases.
Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/31812
Urinalysis segment to achieve notable growth during the forecast period
Based on test type, urinalysis segment held the largest share of more than two-fifths of the global urinary tract infection testing market in 2021 and is expected to dominate the market in 2031. The same segment is expected to show the highest CAGR of 6.7% in 2031, driven by increased demand for diagnosis of urinary tract infections, kidney problems and diabetes from healthcare providers.
Hospital segment will generate the largest revenue during the forecast period
On the basis of end-user, the hospital segment held the largest share of almost half of the global urinary tract infection testing market in 2021 and is expected to lead in 2031. This is due to an increase cases of nosocomial urinary tract infections. . However, the diagnostic laboratory segment is expected to show the highest CAGR of 6.8% in 2031. Laboratory diagnosis is based on colony count after culture which reflects the concentration of organisms in urine.
North America generate the highest revenue by 2031
Based on region, the market for North America was the largest in 2021, accounting for two-fifths of the global urinary tract infection testing market, owing to the presence of major players and high healthcare spending in this region. However, the market for Asia Pacific is likely to dominate in terms of revenue and show the fastest CAGR of 7.4% during the forecast period, due to the increasing geriatric population in this region.
Main market players
- ThermoFisher Scientific, Inc.
- Bio-Rad Laboratories
- Danaher Company
- ACON Laboratories Inc.
- Cardinal Health Inc.
- Stryker Company
- SYSMEX COMPANY
- Abbott Laboratories
- Roche AG
- LabCorp (Laboratory Corporation of America Holdings)
Reports on trends in the healthcare industry (book now with 10% discount):
Urinary Tract Cancer Market by type of cancer (bladder cancer, cancer of the urethra and cancer of the ureter and renal pelvis), type of treatment (chemotherapy and immunotherapy) and distribution channel (retail pharmacy and online pharmacy): Global Opportunity Analysis and Industry Forecast, 2021–2030
Telemedicine market By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology, and Other Applications), Component (Software, Hardware, and Services), and End User (Healthcare Providers, Payers, Health Care Consumers, and Other End Users): Analysis of Global Opportunities and Industry Forecast, 2021-2030
Allergy Diagnostics Market by type of test (in vivo, in vitro), by product and service (consumables, instruments, services), by allergen (inhalant allergens, food allergens, medicinal allergens, other allergens), by end user (diagnostic laboratories, Laboratories, academic research institutes, others): Global Opportunities Analysis and Industry Forecast, 2021-2031
Plasma fractionation market By Product (Albumin, Immunoglobulins, Coagulation Factor VIII and Coagulation Factor IX) and Sector (Public Sector and Private Sector): Global Opportunities Analysis and Industry Forecast, 2020-2027
Digital therapy market by product (software and devices), sales channel (business-to-business and business-to-consumer), application (diabetes, obesity, cardiovascular disease (CVD), central nervous system (CNS), respiratory disease, smoking cessation, gastrointestinal disorders (GID) and Others: Global Opportunities Analysis and Industry Forecast, 2022-2031
Allied Market Research (AMR) is a full-service market research and business advisory division of Allied Analytics LLP based in Portland, OR. Allied Market Research provides global corporations as well as small and medium enterprises with unparalleled quality of “Market research reportsand “Business Intelligence Solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.
We maintain professional relationships with various companies which helps us to extract market data which helps us to generate accurate research data tables and confirm the utmost accuracy of our market predictions. CEO of Allied Market Research Pawan Kumar is essential to inspire and encourage everyone associated with the business to maintain high quality data and help customers in every way possible to achieve success. All data presented in the reports we publish are drawn from primary interviews with senior managers of large companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
UNITED STATES/Canada (Free): +1-800-792-5285, +1-503-894-6022
UNITED KINGDOM: +44-845-528-1300
hong kong: +852-301-84916
India (Pune): +91-20-66346060
SOURCE Allied Market Research